JERUSALEM – Cambridge University Pharmacology Professor Colin Taylor shared with Al Quds University’s community techniques he uses in his lab, and treated students and faculty members to one of his famous lectures on pharmacology, “Signaling to and from IP3 Receptors.” President Dr. Imad Abu Kishek welcomed Taylor:
“Having one of the most prominent researchers in the field of cellular pharmacology worldwide here on our campus is a unique privilege and honor,” said Dr. Abu Kishek about Taylor, who in June 2016, was elected to the prestigious Fellowship of the Academy of Medical Sciences.
Dr. Abu Kishek and Dr. Taylor discussed ways to enhance academic cooperation between Al Quds University and Cambridge University.
“I cannot stress enough the importance of developing research ties with other universities,” Dr. Abu Kishek said after briefing the Cambridge Researcher on the history and latest developments concerning Al-Quds University. He also shared with his guest projects that are being conducted with international universities and institutions.
Al Quds University Executive Vice President Prof. Hassan Dweik gave Dr. Taylor a tour of the facilities, research centers and spoke with him about the “distinguished academic services.”
Al-Quds University (AQU) is a national research university based in Jerusalem, Palestine. Established in 1984 as the only Arab university in the city of Jerusalem, AQU currently offers 93 undergraduate and graduate degree programs, taught through its fifteen degree-granting faculties.